We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans

By HospiMedica International staff writers
Posted on 02 Sep 2025

Liver cancer is the sixth most common cancer worldwide and a leading cause of cancer-related deaths. More...

Accurate segmentation of liver tumors is critical for diagnosis and therapy, but manual methods by radiologists are time-consuming and prone to variations in expertise. Artificial intelligence (AI)-based segmentation has advanced the field, yet most models require thousands of cases for training, creating a barrier to adoption. Now, a groundbreaking AI model has shown high accuracy even with limited training datasets.

Researchers at the Institute of Science Tokyo (Tokyo, Japan) have developed the Multi-scale Hessian-enhanced Patch-based Neural Network (MHP-Net), a deep learning model for liver tumor segmentation. Instead of analyzing entire scans at once, MHP-Net divides images into 3D patches and pairs them with enhanced versions using Hessian filtering, which highlights spherical features like tumors. This architecture creates precise segmentation maps from contrast-enhanced CT scans.

The model’s accuracy was evaluated using Dice similarity scores, which measure overlap between predicted and expert-annotated tumor boundaries. Despite training on datasets as small as 7, 14, and 28 tumors, MHP-Net achieved Dice scores of 0.691, 0.709, and 0.719, respectively. The findings, published in IEEE Access, show the model outperformed established AI systems such as U-Net, Res U-Net, and HDense-U-Net.

In addition to its accuracy, MHP-Net’s lightweight design allows training in under 10 minutes and real-time inference in about four seconds per patient, making it suitable for clinical use with limited computing power. By reducing data requirements, it opens AI adoption to under-resourced hospitals worldwide. Researchers plan to expand the model’s applications, exploring small-data AI solutions for rare cancers and broader medical imaging challenges.

“This is just a start in the field of small-data AI, where meaningful and clinically relevant deep learning models can be built from limited datasets,” said Professor Kenji Suzuki, who led the development of the model. “MHP-Net’s success can inspire small-data AI solutions in other areas of medical imaging as well, such as the detection of rare cancers.”

Related Links:
Institute of Science Tokyo


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.